Research and Markets: Working Capital Management in the North American and European Pharmaceutical Industry 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/mp54qk/working_capital) has announced the addition of the "Working Capital Management in the North American and European Pharmaceutical Industry " report to their offering.

This study analyzes the various working capital components in the pharmaceutical industry. The analysis has been done across the North American and European regions. Companies have also been analyzed for their working capital efficiency and year-on-year growth during the study period 2009 to 2013.

The analysis includes various components of working capital management such as days inventory outstanding, days payable outstanding, days sales outstanding and cash conversion cycle. The study also analyzes the participants in the pharmaceutical industry based on their revenue ranges. It also covers the various trends that impact working capital performance of the participants in the pharmaceutical industry.

M&A: Mergers and acquisitions is an aspect of corporate strategy, corporate finance, and management by which corporations legally unify ownership of assets formerly subject to separate controls. The term deal in the study refers to M&A transactions.

Scope

  • Pharmaceutical Industry: Companies engaged in the research, development, or production of pharmaceuticals.
  • Days Inventory Outstanding: A financial measure of a company's performance that gives investors an idea of how long it takes a company to turn its inventory (including goods that are work in progress, if applicable) into sales.
  • Days Payable Outstanding: Days payable outstanding tells how long it takes a company to pay its invoices from trade creditors, such as suppliers.
  • Days Sales Outstanding: A measure of the average number of days that a company takes to collect revenue after a sale has been made.
  • Cash Conversion Cycle: A metric that expresses the length of time, in days, that it takes for a company to convert resource inputs into cash flows.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. The Key Rationale for Effective Working Capital Management

4. Revenue Range Classification: Revenue Greater Than $10.00 Billion

5. Revenue Range Classification: Revenue Between $1.00 Billion and $10.00 Billion

6. Revenue Range Classification: Revenue Between $50.0 Million and $1.00 Billion

7. Conclusions

8. Appendix

For more information visit http://www.researchandmarkets.com/research/mp54qk/working_capital

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Capital Markets

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Capital Markets